Resmed (RSMDF) Net Margin (2009 - 2026)
Resmed's (RSMDF) quarterly Net Margin came in at 26.2% in Q2 2026, down 197.0% on a YoY basis from 27.01% in Q2 2025, and down 5.96% quarter-over-quarter from 27.86% in Q1 2026.
Powered by 
Analysis
Resmed (RSMDF) Net Margin (2009 - 2026) Analysis & Trends
Resmed (RSMDF) has reported Net Margin for 18 consecutive years, with 26.2% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Margin fell 197.0% year-over-year to 26.2%; the trailing twelve-month figure through Jun 2026 stood at 26.94% (down 27.0% YoY), and the FY2026 full-year result was 26.94%, down 27.0% from the prior year.
- Net Margin slipped to 26.2% in Q2 2026 per RSMDF's latest filing, from 27.86% in the prior quarter.
- Across five years, Net Margin topped out at 28.26% in Q1 2025 and bottomed at 17.96% in Q4 2023.
- Historically, Net Margin has averaged 23.92% across 5 years, with a median of 24.5% in 2024.
- The sharpest annual moves came in 2022 and 2023: Net Margin surged 3092 bps in 2022, then plunged 380 bps in 2023.
- Over 5 years, Net Margin stood at 21.76% in 2022, then fell by 17 bps to 17.96% in 2023, then surged by 50 bps to 26.88% in 2024, then rose by 3 bps to 27.59% in 2025, then dropped by 5 bps to 26.2% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 26.2%, 27.86%, and 27.59% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 177.87 Bn | 7.27 Bn | 7.37% |
| 2 | Intuitive Surgical | 124.18 Bn | 118.96 Bn | 1.96 Bn | 28.46% |
| 3 | Medtronic | 118.17 Bn | 109.35 Bn | 6.34 Bn | 15.17% |
| 4 | Stryker | 106.33 Bn | 102.85 Bn | 4.50 Bn | 19.37% |
| 5 | Boston Scientific | 66.46 Bn | 65.93 Bn | 3.85 Bn | 16.67% |
| 6 | Edwards Lifesciences | 49.59 Bn | 45.34 Bn | 1.35 Bn | 13.87% |
| 7 | Alcon | 33.96 Bn | 32.51 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.98 Bn | 30.03 Bn | 830.00 Mn | 19.04% |
| 9 | Steris | 21.10 Bn | 20.62 Bn | 684.20 Mn | 13.47% |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | 26.20% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.20% |
| Mar 31, 2026 | 27.86% |
| Dec 31, 2025 | 27.59% |
| Sep 30, 2025 | 26.10% |
| Jun 30, 2025 | 28.17% |
| Mar 31, 2025 | 28.26% |
| Dec 31, 2024 | 26.88% |
| Sep 30, 2024 | 25.43% |
| Jun 30, 2024 | 23.89% |
| Mar 31, 2024 | 25.10% |
| Dec 31, 2023 | 17.96% |
| Sep 30, 2023 | 19.91% |
| Jun 30, 2023 | 20.47% |
| Mar 31, 2023 | 20.82% |
| Dec 31, 2022 | 21.76% |
| Sep 30, 2022 | 22.15% |
| Jun 30, 2022 | 21.32% |
| Mar 31, 2022 | 20.71% |
| Dec 31, 2021 | 22.55% |
| Sep 30, 2021 | 22.52% |